Angiotensin-converting enzyme I/D and α-adducin Gly460Trp polymorphisms: From angiotensin-converting enzyme activity to cardiovascular outcome

Hypertension

Volumn 49, Issue 6, 2007, Pages 1291-1297

  Li, Yan ^a,d   Zagato, Laura ^b   Kuznetsova, Tatiana ^a   Tripodi, Grazia ^c   Zerbini, Gianpaolo ^b   Richart, Tom ^a   Thijs, Lutgarde ^a   Manunta, Paolo ^b   Wang, Ji Guang ^d   Bianchi, Giuseppe ^b   Staessen, Jan A ^a,e  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Prassis Sigma Tau Research Institute   (Italy)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e Studies Coordinating Centre   (Belgium)

Author keywords

Adducin; Angiotensin converting enzyme; Clinical genetics; Epidemiology; Risk factors

Indexed keywords

ALPHA ADDUCIN; DIPEPTIDYL PEPTIDASE I; GLYCINE; HIPPURIC ACID; TRYPTOPHAN;

ADULT; ALLELE; ARTICLE; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL STRAIN HEK293; CONTROLLED STUDY; DISEASE REGISTRY; EMBRYO; ENZYME ACTIVITY; EPIDEMIOLOGICAL DATA; FEMALE; FIBROBLAST; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC TRANSFECTION; HEART FAILURE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEMBRANE BINDING; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

AGED; CALMODULIN-BINDING PROTEINS; CARDIOVASCULAR DISEASES; CELL LINE; CELLS, CULTURED; DIURETICS; FEMALE; GLYCINE; HOMOZYGOTE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUTATION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TRYPTOPHAN;

EID: 34249294059     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.106.085498     Document Type: Article

References (34)

1. Muntau AC, Roschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff CP, Roscher AA. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med. 2002;347:2122-2132.
2. Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev. 2001;2:245-255.
3. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the converting-enzyme and cardiovascular-renal risk. J Hypertens. 1997;15:1579-1592.
4. Navar LG, Nishiyama A. Why are angiotensin concentrations so high in the kidney? Curr Opin Nephrol Hypertens. 2004;13:107-115.
5. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Battle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol. 2006;17:3067-3075.
6. Hashimoto S, Adams JW, Bernstein KE, Schnermann J. Micropuncture determination of nephron function in mice without tissue angiotensin-converting enzyme. Am J Phys. 2005;288:F445-F452.
7. Müller DN, Bohlender J, Hilgers KF, Dragun D, Costerousse O, Ménard J, Luft FC. Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension. 1997;29:98-104.
8. Danser AHJ, Schalekamp MADH, Bax WA, van den Brink AM, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 1995;92:1387-1388.
9. Bianchi G. Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms. Am J Physiol. 2005;289:R1536-R1549.
10. +-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res. 2004;45:331-340.
11. Pedrinelli R, Dell'Omo G, Penno G, Di Bello V, Pucci L, Fotino C, Lucchesi D, Del Prato S, Dal Fiume C, Barlassina C, Cusi D. α-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria. J Hypertens. 2006;24:931-937.
12. Barlassina C, Schork NJ, Manuta P, Citterio L, Sciarrone MT, Lanella G, Bianchi G, Cusi D. Synergistic effect of -adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int. 2000;57:1083-1090.
13. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhäger WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens. 2001;19:1349-1358.
14. Wang JG, Staessen JA, Tizzoni L, Brand E, Birkenhäger WH, Fagard R, Herrmann SM, Bianchi G. Renal function in relation to three candidate genes. Am J Kidney Dis. 2001;38:1158-1168.
15. Balkestein EJ, Wang JG, Struijker-Boudier HAJ, Barlassina C, Bianchi G, Birkenhäger WH, Brand E, Den Hond E, Fagard R, Herrmann SM, Van Bortel L, Staessen JA. Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J Hypertens. 2002;20:1551-1561.
16. Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, Wang J, Li Y, Bianchi G, Staessen JA, Liu L. Renal function in relation to three candidate genes in a Chinese population. J Mol Med. 2004;82:715-722.
17. Li Y, Thijs L, Kuznetsova T, Zagato L, Struijker-Boudier H, Bianchi G, Staessen JA. Cardiovascular risk in relation to α-adducin Gly460Trp polymorphism and systolic pressure. A prospective population study. Hypertension. 2005;46:527-532.
18. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
19. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med. 2000;343:141-144.
20. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J. 1993;290:33-40.
21. Zagato L, Paroni R, Fermo I, Zerbini G, Maestroni A, Dal Fiume C, Barlassina C. Direct assessment of angiotensin-converting enzyme activity on the surface of human skin fibroblasts in culture [published correction appears in Anal Biochem. 2005;338:301]. Anal Biochem. 2005;338:334-346.
22. Cushman DW, Cheung HS. Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta. 1971;250:261-265.
23. Meng QC, Balcells E, Dell'Italia L, Durand J, Oparil S. Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue. Biochem Pharmacol. 1995;50:1445-1450.
24. Page GP, George V, Go RC, Page PZ, Allison DB. "Are we there yet?": deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. Am J Hum Genet. 2003;73:711-719.
25. Kuznetsova T, Staessen JA, Brand E, Cwynar M, Stolarz K, Thijs L, Tikhonoff V, Wojciechowska W, Babeanu S, Brand-Herrmann SM, Casiglia E, Filipovský J, Grodzicki T, Nikitin Y, Peleška J, Struijker-Boudier HA, Bianchi G, Kawecka-Jaszcz K, on behalf of the European Project on Genes in Hypertension (EPOGH) Investigators. Sodium excretion as modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in Hypertension. J Hypertens. 2006;24:235-242.
26. Bianchi G, Tripodi G, Casari G, Salardi S, Barber BR, Garcia R, Leoni P, Torielli L, Cusi D, Ferrandi M, Pinna LA, Baralle FE, Ferrari P. Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci U S A. 1994;91:3999-4003.
27. Tripodi G, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L, Menegon A, Ferrari P, Marchisio PC, Bianchi G. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest. 1996;97:2815-2822.
28. Staessen JA, Li Y, Richart T. Oral renin inhibitors. Lancet. 2006;346:1449-1456.
29. Buikema H, Pinto YM, Rooks G, Grandjean JG, Schunkert H, van Gilst WH. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J. 1996;17:787-794.
30. Schut AFC, Bleumink GS, Stricker BHC, Hofman A, Witteman JCM, Pols HAP, Deckers JW, Deinum J, van Duijn CM. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J. 2004;25:2143-2148.
31. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JCM. ACE polymorphisms. Circ Res. 2006;98:1123-1133.
32. Sciarrone MT, Stella P, Barlassina C, Manunta P, Lanzani C, Bianchi G, Cusi D. ACE and α-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension. 2003;41:398-403.
33. Psaty BM, Smith NL, Hecbert SR, Vos HL, Lemaitre RN, Reiner AP, Siscovick DS, Bis J, Lumley T, Longstreth WT Jr, Rosendaal FR. Diuretic therapy, the α-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA. 2002;287:1680-1690.
34. Morrison AC, Bray MS, Folsom AR, Boerwinkle E. ADD1 460W allele associated with cardiovascular disease in hypertensive individuals. Hypertension. 2002;39:1053-1057.